` RJF (Laboratorio Reig Jofre SA) vs DAX Index Comparison - Alpha Spread

RJF
vs
DAX Index

Over the past 12 months, RJF has underperformed DAX Index, delivering a return of 10% compared to the DAX Index's 22% growth.

Stocks Performance
RJF vs DAX Index

Loading
RJF
DAX Index
Add Stock

Performance Gap
RJF vs DAX Index

Loading
RJF
DAX Index
Difference

Performance By Year
RJF vs DAX Index

Loading
RJF
DAX Index
Add Stock

Competitors Performance
Laboratorio Reig Jofre SA vs Peers

DAX Index
RJF
LLY
JNJ
NOVO B
ROG
Add Stock

Laboratorio Reig Jofre SA
Glance View

Market Cap
220.2m EUR
Industry
Pharmaceuticals

Laboratorio Reig Jofre SA engages in the research, development, manufacture, and trade of pharmaceutical drugs. The company is headquartered in Sant Joan Despi, Barcelona and currently employs 1,152 full-time employees. The company went IPO on 2006-11-07. The Company’s activities are divided into four business divisions: Industrial Services, providing production services for third parties; Pharma, selling own pharmaceuticals under a range of brands, such as Reig Jofre, Medea, Orravan, Bioglan and Sala; Reaserch and Development (R&D) and Regulatory, including the development of indications for existing molecules, as well as generics and molecular diagnostics, among others; and Biotech, offering biopharmaceutical support services, such as analytical and process development, quality control and assurance, as well as stability studies. The firm also provides nutritional cosmetics, and food supplements, among others. The company operates worldwide in Europe, Africa, the Americas, Australia and Asia through a number of subsidiaries, including Chiesi Espana SA and Oryzon Genomics SA.

RJF Intrinsic Value
2.86 EUR
Undervaluation 4%
Intrinsic Value
Price
Back to Top